Besides FGF8, FGF18, and FGFR4 the factors age, gender, tumor differentiation, UICC stage, lymph node ratio, adjuvant treatment, and Mandard regression grade (in neoadjuvantly treated patients only) were included. The gene discussed is FGF18; the disease is neoplasm.